Sign Out
Gastrointestinal effects: Most common symptoms include glossitis, stomatitis, nausea, vomiting, enterocolitis, and diarrhea. Few cases of pseudomembranous colitis have been reported.
Hepatic: Rarely, moderate rise in aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) have been noted.
Hematologic and Lymphatic Systems: Anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, and agranulocytosis have been reported but are usually reversible on discontinuation of therapy.
Central Nervous System: Reversible hyperactivity, agitation, anxiety, insomnia, confusion, behavioral changes, and/or dizziness have been reported rarely.
View ADR Reporting Link
